Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:14.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with basic site chrome, replacing the previous study record content and indicating an access-denied state.
    Difference
    21%
    Check dated 2026-09-19T22:01:16.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study record now includes an NIH funding note (2018) in the identifiers section, indicating U.S. NIH support for the trial. The page's revision line was updated to Revision: v3.6.6, replacing the older v3.6.5 tag.
    Difference
    0.1%
    Check dated 2026-08-29T21:48:21.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, replacing the previous v3.6.4 in the revision history. This reflects a small update to the page's metadata without altering study information.
    Difference
    0.0%
    Check dated 2026-08-08T18:25:51.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page. This reflects a minor revision history update without altering the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-25T11:42:40.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, signaling a minor platform update to the study page. This change reflects backend/content refresh rather than any new information about the trial itself.
    Difference
    0.0%
    Check dated 2026-07-03T22:55:33.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.